These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 36867370)
21. IL-1 Family Antagonists in Mouse and Human Skin Inflammation. Martin P; Goldstein JD; Mermoud L; Diaz-Barreiro A; Palmer G Front Immunol; 2021; 12():652846. PubMed ID: 33796114 [TBL] [Abstract][Full Text] [Related]
22. Serum IL-36α, IL-36β, and IL-36γ levels in patients with hidradenitis suppurativa: association with disease characteristics, smoking, obesity, and metabolic syndrome. Hayran Y; Allı N; Yücel Ç; Akdoğan N; Turhan T Arch Dermatol Res; 2020 Apr; 312(3):187-196. PubMed ID: 31722038 [TBL] [Abstract][Full Text] [Related]
23. Spesolimab: a comprehensive review on the anti-IL-36 receptor antibody in dermatology. Palaniappan V; Gopinath H; Murthy AB; Radhakrishnan S; Karthikeyan K Int J Dermatol; 2024 Jan; 63(1):88-93. PubMed ID: 38031264 [TBL] [Abstract][Full Text] [Related]
24. Psoriasis and other Th17-mediated skin diseases. Tokura Y; Mori T; Hino R J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422 [TBL] [Abstract][Full Text] [Related]
25. Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease. Andoh A; Nishida A J Gastroenterol; 2023 Feb; 58(2):69-78. PubMed ID: 36376594 [TBL] [Abstract][Full Text] [Related]
26. Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa. Thomi R; Kakeda M; Yawalkar N; Schlapbach C; Hunger RE J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2091-2096. PubMed ID: 28602023 [TBL] [Abstract][Full Text] [Related]
27. The role of interleukin-36 in health and disease states. Sugiura K; Fujita H; Komine M; Yamanaka K; Akiyama M J Eur Acad Dermatol Venereol; 2024 Oct; 38(10):1910-1925. PubMed ID: 38779986 [TBL] [Abstract][Full Text] [Related]
28. IL-36 cytokines and gut immunity. Ngo VL; Kuczma M; Maxim E; Denning TL Immunology; 2021 Jun; 163(2):145-154. PubMed ID: 33501638 [TBL] [Abstract][Full Text] [Related]
29. Increased expression of interleukin 36 in chronic rhinosinusitis and its contribution to chemokine secretion and increased epithelial permeability. Joo YH; Kim HK; Hak Choi I; Han HM; Lee KJ; Kim TH; Lee SH Cytokine; 2020 Jan; 125():154798. PubMed ID: 31430658 [TBL] [Abstract][Full Text] [Related]
30. IL-36α and IL-36γ expressions in the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema: A retrospective histopathologic and immunohistochemical study. Erdem O; Leblebici C; Koku Aksu AE; Erdil D; Kara Polat A; Gürel MS J Cutan Pathol; 2022 Jan; 49(1):42-48. PubMed ID: 34289144 [TBL] [Abstract][Full Text] [Related]
31. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases. Walsh PT; Fallon PG Ann N Y Acad Sci; 2018 Apr; 1417(1):23-34. PubMed ID: 27783881 [TBL] [Abstract][Full Text] [Related]
32. Mature IL-36γ Induces Stratum Corneum Exfoliation in Generalized Pustular Psoriasis by Suppressing Corneodesmosin. Sato E; Imayoshi H; Tsutsui Y; Shimizu H; Imafuku S J Invest Dermatol; 2024 Apr; 144(4):764-773.e4. PubMed ID: 37827276 [TBL] [Abstract][Full Text] [Related]
33. IL-36 Cytokines: Their Roles in Asthma and Potential as a Therapeutic. Dong H; Hao Y; Li W; Yang W; Gao P Front Immunol; 2022; 13():921275. PubMed ID: 35903102 [TBL] [Abstract][Full Text] [Related]
34. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression. Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104 [TBL] [Abstract][Full Text] [Related]